drug
as of 2026-07-01Oxcarbazepine
MeSH D000078330
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
2
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia
NCT00637234Phase 2, Phase 3Completed
KOLs & investigators
2
F. Markus Leweke, MDKOL score 9
Helge Frieling, Prof., MDKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
KOL
F. Markus Leweke, MD
personKOL score 9
Helge Frieling, Prof., MD
personKOL score 5